Insider trade

Director sold ~$579K of UTHR shares in the open market

Traded Apr 17, 2026 · Filed Apr 18, 2026

Why it stands out

A United Therapeutics director sold $579K of United Therapeutics shares. The filing says it was made under a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$500K–$1MPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$578,880

Shares × reported transaction price

Timing vs results

51 days after results of Feb 25, 2026, 19 days before results of May 6, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 18, 2025.

Filed 5mo ago

Traded May 14 · filed 2 days later

Derivative exercise or conversion — not an open-market buy.

Scheduled in advanceFiled 5mo ago

Scheduled in advanceFiled 5mo ago